My guest in this episode is Brandon Rice.

Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation.

In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline processes, and the importance of human oversight in AI-generated content. The discussion also touches on the cultural differences in AI adoption among pharmaceutical companies, global regulatory trends, and the need for open-mindedness towards new technologies.

I thoroughly enjoyed my chat with Brandon and learned a lot about the current AI in pharma landscape. I hope you do too.

Here's Brandon Rice.